Neumora Therapeutics NMRA
NASDAQ NMRA
$0.42 +0.01 (+1.47%)
As of: Oct 22, 2026 · 10:38 AM EDT

Neumora Therapeutics (NMRA) Other Operating Expenses (2023 - 2025)

Updated

Neumora Therapeutics (NMRA) posted Other Operating Expenses of $5 million for FY2025.

Analysis

Neumora Therapeutics (NMRA) Other Operating Expenses (2023 - 2025) Analysis & Trends

  • Annual Other Operating Expenses shows a three-year compound annual growth rate of -27.3% (FY2022 to FY2025).
  • Business Quant data shows NMRA's Other Operating Expenses at $63.9 million in FY2023 (+391.6%) and $13 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,163.39 Bn 1,131.97 Bn 19.71 Bn
2 Johnson & Johnson 634.39 Bn 552.91 Bn 17.26 Bn
3 AbbVie 502.68 Bn 475.79 Bn 12.70 Bn
4 Merck 377.37 Bn 331.74 Bn 12.21 Bn
5 Novartis Ag 303.41 Bn 267.40 Bn 11.24 Bn
6 Astrazeneca 266.55 Bn 240.24 Bn 12.86 Bn
7 Amgen 240.56 Bn 195.96 Bn 7.24 Bn
8 Gilead Sciences 193.19 Bn 167.38 Bn 6.22 Bn
9 Pfizer 172.14 Bn 118.78 Bn 10.94 Bn
10 Neumora Therapeutics 77.95 Mn -540.01 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 5.00 Mn
Dec 31, 2023 63.90 Mn
API Access

Neumora Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=NMRA&period=max&api_key=YOUR_API_KEY